Peter A. Noseworthy - Concepedia

Author

Peter A. Noseworthy

Also Known As

Daníel F Gudbjartsson, James IV Hamilton, John H. Ip, Noseworthy, Peter A, Noseworthy, Peter A., P A Noseworthy, P Noseworthy, P. A. Noseworthy, P. Noseworthy, P.A Noseworthy

726

Publications

28.1K

Citations

H-Index

187

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Mayo Clinic in Florida WinnMed Optum (United States)

About

Peter A. Noseworthy is an author at Mayo Clinic specializing in medicine, cardiology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	87	9.7K
2	Engineering	10	10	1.7K
3	Health Sciences	5	5	367
4	Education	1	1	16
5	Natural Sciences	1	1	66

Peter A. Noseworthy

226

Publications

21.1K

Citations

H-Index

Page 1

	Year	Citations
An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction Zachi I. Attia, Peter A. Noseworthy, Francisco López-Jiménez, The Lancet Artificial IntelligenceElectrophysiological EvaluationEngineeringIntelligent DiagnosticsData Science	2019	1.4K
Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation Douglas L. Packer, Daniel B. Mark, Richard A. Robb, JAMA	2019	1.4K
Screening for cardiac contractile dysfunction using an artificial intelligence–enabled electrocardiogram Zachi I. Attia, Suraj Kapa, Francisco López-Jiménez, Nature Medicine Biomedical Artificial IntelligenceElectrophysiological EvaluationIntelligent DiagnosticsDiagnosisBiostatistics	2018	1.2K
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation José A. Joglar, Mina K. Chung, Anastasia L. Armbruster, Journal of the American College of Cardiology Electrophysiological EvaluationAcc/aha/accp/hrs GuidelineCardiovascular DiseaseAtrial FibrillationPublic Health	2023	606
Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States Konstantinos C. Siontis, Xiaosong Zhang, Ashley Eckard, Circulation	2018	472
Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction Xiaoxi Yao, Nilay D. Shah, Lindsey R. Sangaralingham, Journal of the American College of Cardiology ThrombosisCardiovascular DiseaseChronic Kidney DiseasePharmacologyCardiovascular Pharmacology	2017	459
Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, Journal of the American Heart Association	2016	449
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure Douglas L. Packer, Jonathan P. Piccini, Kristi H. Monahan, Circulation	2021	448
2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation Stylianos Tzeis, Edward P. Gerstenfeld, Jonathan M. Kalman, EP Europace	2024	443
Age and Sex Estimation Using Artificial Intelligence From Standard 12-Lead ECGs Zachi I. Attia, Paul A. Friedman, Peter A. Noseworthy, Circulation Arrhythmia and Electrophysiology	2019	415

Page 1